Company Profile

Electrical Geodesics Inc (AKA:Egi~cerebral Data Systems Inc)
Profile last edited on: 2/22/22      CAGE: 1W6F4      UEI: GA2MMT1QL2B3

Business Identifier: Diagnostic and monitoring equipment for neurological applications
Year Founded
First Award
Latest Award
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

500 East 4th Avenue Suite 200
Eugene, OR 97401
   (541) 687-7962
Location: Multiple
Congr. District: 04
County: Lane

Public Profile

With the declared objective of establishing integrated neurological imaging, mapping and therapy guidance portfolio, in June 2017 Royal Philips (NYSE: PHG, AEX: PHIA), announced an agreement to acquire Electrical Geodesics, Inc. (EGI). In an interesting follow-on to that transaction, it was announced in July 2020 that Transcranial magnetic stimulation tech developer Magstim had purchased the product portfolio of Electrical Geodesics from Royal Philips (NYSE:PHG). Extensively SBIR involved - 33 Phase I and 23 Phase II - EGI ia a US-based medical device company designing, developing and commercializing a range of non-invasive technologies used to monitor and interpret brain activity. The firm's portfolio of EEG hardware, software and acquisition sensors were discussed as complementing Philips’ existing portfolio of imaging technologies (e.g. MRI and PET-CT) and advanced informatics (e.g. IntelliSpace Portal) for neurological applications. The combined portfolios had been discussed as enabling Philips to address neurological disorders such as stroke, epilepsy, traumatic brain injury and Parkinson’s disease. EGI - Electrical Geodesics Inc - is a neurodiagnostic medical technology company developing a range of non-invasive neurodiagnostic products used to monitor and interpret brain activity. In April 2013, the firm went public on London's AIM Exchange. EGI’s core technology, Geodesic EEG, provides non-invasive and high-resolution imaging of brain activity and is used to study a broad range of brain disorders, including epilepsy, autism, stroke, traumatic brain injury, and sleep disorders. EGI's new Geodesic Transcranial Electrical Neuromodulation (GTEN) technology was demonstrated at the Human Brain Mapping meeting in Honolulu. GTEN integrates EGI's core GES 400 dEEG platform and its proprietary head modeling algorithms to create a new technique for very precise neuromodulation. Released first for use in research, potential future medical applications for the new technology include epilepsy, depression, and tinnitus, among ot

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Publicly Traded
Stock Info
AIM - Lond : EGI
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2017 2 NIH $1,142,817
Project Title: Multimodal Image Analysis Software for Epilepsy
2016 2 NIH $2,373,677
Project Title: Pediatric Head Models for Improved Imaging of Neurological Development
2016 2 NIH $2,452,240
Project Title: High-Field MR-Compatible Dense Array EEG Using Polymer Thick Film Technology
2013 2 NIH $1,128,923
Project Title: Integrated EEG/NIR Sensor System for Infants
2013 2 NIH $1,000,524
Project Title: Detection And Quantification Of Neonatal Intraventricular Hemorrhage

Key People / Management

  Ann Bunnenberg -- President/COO/Co-Founder

  K Jeffrey Eriksen

  Paul Holman -- General Manager

  Phan Luu -- Chief Technology Officer

  Ted Mondson

  Paul Nunez

  Stacey Pederson -- Scientist

  Pieter Poolman -- Scientist

  Catherine Poulsen

  Gerald S Russell

  Rosalind J Sadleir

  Don M Tucker -- Chief Executive Officer

  Sergei Turovets